GO:0006559 L-phenylalanine catabolic process: Metabolic Checkpoint, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006559 (L-phenylalanine catabolic process) describes the biochemical reactions and pathways that break down L-phenylalanine, an essential aromatic amino acid, into downstream metabolites.
• Catabolism of L-phenylalanine proceeds through transamination to phenylpyruvate and can be routed through the Ehrlich pathway to 2-phenylethanol, a route extensively engineered in microbes.
• L-phenylalanine itself acts as a metabolic checkpoint in human Th2 cells, linking its availability and catabolism to immune cell fate decisions.
• Enzymes such as L-amino acid oxidases and transaminases catalyze key oxidative and transamination steps in L-phenylalanine breakdown.
• Disrupted L-phenylalanine catabolism is relevant to neurological symptoms associated with phenylalanine-derived metabolites and to metabolic engineering of high-value compounds.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of genes controlling L-phenylalanine catabolic flux.
Description
L-phenylalanine is an essential aromatic amino acid that must be obtained from the diet and is subsequently partitioned between protein synthesis and catabolic disposal. The Gene Ontology term GO:0006559, L-phenylalanine catabolic process, defines the chemical reactions and pathways resulting in the breakdown of L-phenylalanine. This process is central to aromatic amino acid homeostasis and generates metabolites that feed into diverse physiological and biotechnological outputs. Understanding its regulation is important because L-phenylalanine levels and catabolic flux influence immune cell function and neurological status. In microbial systems, the catabolic and biosynthetic routes surrounding L-phenylalanine have been harnessed for the production of phenylalanine-derived compounds, including 2-phenylethanol and phenylpyruvic acid. The same enzymatic logic, involving transamination and oxidative deamination, recurs across organisms and provides a tractable target for metabolic engineering. Consequently, GO:0006559 sits at the intersection of amino acid metabolism, immunometabolism, neurochemistry, and industrial biotechnology.
L-phenylalanine catabolic process At A Glance
| GO ID | GO:0006559 |
|---|---|
| GO term | L-phenylalanine catabolic process |
| Ontology | biological_process |
| Definition | The chemical reactions and pathways resulting in the breakdown of L-phenylalanine. |
| Synonyms | L-phenylalanine breakdown; L-phenylalanine catabolism; L-phenylalanine degradation; L-phenylalanine catabolic process via Ehrlich pathway; phenylalanine catabolic process |
| Major function | Breakdown of L-phenylalanine into phenylpyruvate and related metabolites, feeding the Ehrlich pathway and aromatic compound metabolism |
| Key enzymatic step | Transamination or oxidative deamination of L-phenylalanine to phenylpyruvate |
| Representative organisms | Escherichia coli, yeast, fungi, and human cells |
| Related disease relevance | Neurological symptoms linked to phenylalanine-derived metabolites and immune cell metabolic checkpoints |
What Is GO:0006559?
GO:0006559, L-phenylalanine catabolic process, is the biological process comprising the chemical reactions and pathways that result in the breakdown of L-phenylalanine. It encompasses the enzymatic conversion of L-phenylalanine into downstream intermediates such as phenylpyruvate and, in some organisms, further conversion through the Ehrlich pathway to compounds like 2-phenylethanol. The term is synonymous with L-phenylalanine breakdown, L-phenylalanine catabolism, L-phenylalanine degradation, and phenylalanine catabolic process.
Why Is L-phenylalanine catabolic process Important in Cell Biology?
L-phenylalanine catabolic process is important because it controls the fate of an essential amino acid and determines the supply of aromatic metabolites that influence immunity, neurophysiology, and microbial production of valuable compounds. In human Th2 cells, L-phenylalanine acts as a metabolic checkpoint, meaning its availability and catabolism can shape immune responses. In the nervous system, altered handling of phenylalanine and its derivatives has been associated with neurophysiological symptoms. In biotechnology, the catabolic and adjacent biosynthetic routes are exploited to produce L-phenylalanine-derived compounds such as 2-phenylethanol and phenylpyruvic acid. Thus, GO:0006559 is a nexus for both fundamental metabolism and translational applications.
• Controls the breakdown of an essential aromatic amino acid, L-phenylalanine, and prevents its accumulation.
• Supplies phenylpyruvate, a precursor for further catabolic and biosynthetic routes.
• Feeds the Ehrlich pathway leading to 2-phenylethanol, a high-value aroma compound.
• Acts as a metabolic checkpoint in human Th2 cells, linking amino acid catabolism to immune function.
• Relevant to neurological symptoms associated with phenylalanine-derived metabolites.
• Enables microbial production of L-phenylalanine-derived compounds through engineered catabolic/biosynthetic flux.
• Provides targets for metabolic engineering of Escherichia coli and other hosts.
• Offers a model system for studying transamination and oxidative deamination enzymology.
• Supports the development of biomedical materials derived from phenylalanine-based polymers.
• Creates opportunities for CRISPR-based causal gene validation in metabolic pathways.
What Happens During L-phenylalanine catabolic process?
Uptake and availability of L-phenylalanine
In simple terms: First, the cell must have L-phenylalanine available before it can break it down.
L-phenylalanine is an essential amino acid, so its intracellular pool depends on transport and dietary supply. In human Th2 cells, L-phenylalanine availability functions as a metabolic checkpoint, indicating that the amount of substrate accessible to catabolic enzymes is itself a regulatory signal. In microbial systems, L-phenylalanine overproduction and catabolism are tightly connected to central carbon and aromatic amino acid metabolism.
Transamination to phenylpyruvate
In simple terms: The first major breakdown step removes the amino group and converts L-phenylalanine into phenylpyruvate.
A central route of L-phenylalanine catabolism is transamination, which transfers the amino group to an acceptor and yields phenylpyruvate. This step is a gateway to downstream aromatic metabolites and is a common target in metabolic engineering. The resulting phenylpyruvate can be further converted in the Ehrlich pathway or related routes.
Oxidative deamination by L-amino acid oxidases
In simple terms: Some organisms use an oxidase enzyme to remove the amino group oxidatively, also producing phenylpyruvate.
L-amino acid oxidases can catalyze the oxidative deamination of L-phenylalanine to phenylpyruvic acid. An L-amino acid oxidase from Hebeloma cylindrosporum has been characterized for the synthesis of phenylpyruvic acid from L-phenylalanine, demonstrating the enzymatic feasibility of this catabolic step. This reaction provides an alternative to transamination for initiating L-phenylalanine breakdown.
Ehrlich pathway and 2-phenylethanol formation
In simple terms: After the first breakdown step, the carbon skeleton can be converted into aroma compounds like 2-phenylethanol.
The Ehrlich pathway converts L-phenylalanine-derived phenylpyruvate into 2-phenylethanol via decarboxylation and reduction steps. Biotechnological production of 2-phenylethanol has been extensively developed, and the pathway is a direct extension of L-phenylalanine catabolism. Engineered microbes can be constructed to produce L-phenylalanine-derived compounds through this route.
Integration with aromatic compound biosynthesis
In simple terms: Breakdown products of L-phenylalanine can be reused to make other valuable aromatic molecules.
L-phenylalanine catabolic intermediates intersect with biosynthetic pathways for L-phenylalanine-derived compounds. Engineered microbes have been designed to produce such compounds by balancing catabolic and biosynthetic flux. Transcriptomic and metabolomic analyses of L-phenylalanine overproduction in Escherichia coli reveal how these routes are coordinated.
Key Genes Involved in GO:0006559 L-phenylalanine catabolic process
The following genes and proteins are experimentally implicated in L-phenylalanine catabolism or in the production of L-phenylalanine-derived compounds, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| L-amino acid oxidase (Hebeloma cylindrosporum) | Oxidative deamination of L-phenylalanine to phenylpyruvic acid | Enzymatic synthesis of phenylpyruvic acid |
| Ehrlich pathway enzymes (yeast) | Conversion of phenylpyruvate to 2-phenylethanol | Biotechnological 2-phenylethanol production |
| Escherichia coli aromatic amino acid transaminases | Transamination of L-phenylalanine to phenylpyruvate | Metabolic engineering of L-phenylalanine-derived compounds |
| Escherichia coli central metabolic genes | Supply precursors and cofactors for L-phenylalanine metabolism | Transcriptomics and metabolomics of overproduction |
| Th2 cell metabolic genes | L-phenylalanine checkpoint control in immune cells | Immunometabolism and Th2 cell fate |
| Phenylalanine-derived polymer synthesis genes | Poly(phenylalanine) and poly(3,4-dihydroxy-L-phenylalanine) production | Biomedical material development |
| Aromatic amino acid biosynthesis genes | Balance L-phenylalanine pool and catabolic flux | Engineered microbial production |
| Phenylpyruvate decarboxylase (Ehrlich pathway) | Decarboxylation of phenylpyruvate | 2-Phenylethanol biosynthesis |
| Alcohol dehydrogenase (Ehrlich pathway) | Reduction of phenylacetaldehyde to 2-phenylethanol | 2-Phenylethanol biosynthesis |
| Transaminase genes in E. coli | Reversible amino group transfer | Metabolic flux control |
| L-amino acid oxidase homologs | Oxidative deamination | Biocatalysis and phenylpyruvic acid synthesis |
| Aspartame metabolism-related genes | Release of L-phenylalanine from aspartame | Neurophysiological symptom studies |
| Th2 cytokine genes | Downstream of L-phenylalanine checkpoint | Immune cell function |
| Aromatic compound exporter genes | Export of 2-phenylethanol and related metabolites | Biotechnological production |
| Phenylalanine hydroxylase-related genes | Alternative aromatic amino acid handling | Metabolic context |
| E. coli shikimate pathway genes | Precursor supply for aromatic amino acids | Overproduction studies |
| Yeast Ehrlich pathway regulators | Transcriptional control of catabolic flux | 2-Phenylethanol engineering |
| Microbial stress response genes | Tolerance to aromatic compounds | Production strain improvement |
How Is L-phenylalanine catabolic process Regulated?
L-phenylalanine catabolic process is regulated at multiple levels. In human Th2 cells, L-phenylalanine itself acts as a metabolic checkpoint, meaning its concentration and catabolic handling influence cell state decisions. In microorganisms, the flux through catabolic and biosynthetic routes is coordinated with central metabolism, as shown by transcriptomic and metabolomic analyses of L-phenylalanine overproduction in Escherichia coli. The Ehrlich pathway, which extends L-phenylalanine catabolism to 2-phenylethanol, is subject to pathway-specific enzymatic control that has been targeted in biotechnological production. Additionally, the availability of L-phenylalanine from sources such as aspartame can influence the substrate pool for catabolic enzymes and has been linked to neurophysiological symptoms.
L-phenylalanine catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Th2 cell metabolic genes | Immune cell metabolic checkpoint | CRISPR knockout in primary human Th2 cells |
| Aspartame metabolism-related genes | Neurophysiological symptoms | Point-mutation models in neuronal cell lines |
| Ehrlich pathway enzymes | 2-Phenylethanol production | Overexpression in yeast |
| L-amino acid oxidase | Phenylpyruvic acid synthesis | Knock-in in microbial hosts |
| E. coli aromatic amino acid genes | L-phenylalanine overproduction | Knockout and overexpression in E. coli |
L-phenylalanine catabolism and neurophysiological symptoms
Altered handling of L-phenylalanine and its derivatives has been associated with neurophysiological symptoms. Aspartame, which releases L-phenylalanine upon metabolism, has been examined for its connection to such symptoms, highlighting the importance of understanding L-phenylalanine catabolic flux in the nervous system.
L-phenylalanine as a metabolic checkpoint in immunity
In human Th2 cells, L-phenylalanine functions as a metabolic checkpoint, linking amino acid availability and catabolism to immune cell function. This positions GO:0006559 as a process relevant to immunometabolism and potential immune-related conditions.
Biotechnological and biomedical implications
L-phenylalanine-derived compounds produced through catabolic and biosynthetic routes are used in biotechnology and biomedicine. Poly(phenylalanine) and poly(3,4-dihydroxy-L-phenylalanine) are promising biomedical materials for stimuli-responsive nanocarriers, connecting L-phenylalanine metabolism to materials science. Engineered microbes producing L-phenylalanine-derived compounds further illustrate translational potential.
From L-phenylalanine catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for L-phenylalanine catabolism? | CRISPR knockout cell model |
| Does a specific amino acid substitution alter enzyme activity? | Point-mutation knock-in cell model |
| Can a tagged enzyme be tracked in living cells? | Tagged knock-in cell model |
| Does overexpression increase catabolic flux? | Overexpression cell model |
| Which genes control the L-phenylalanine checkpoint in immune cells? | CRISPR library screening in Th2 cells |
| How does L-phenylalanine overproduction reshape metabolism? | Transcriptomics and metabolomics in E. coli |
How to Study the L-phenylalanine catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transcriptomics | Gene expression changes | L-phenylalanine overproduction in E. coli |
| Metabolomics | Metabolite pools and flux | Aromatic amino acid metabolism |
| Enzyme kinetics | Catalytic activity of catabolic enzymes | L-amino acid oxidase characterization |
| Metabolic engineering | Product yield from engineered pathways | 2-Phenylethanol production |
| Immunometabolic assays | L-phenylalanine checkpoint in immune cells | Th2 cell studies |
| CRISPR knockout | Gene requirement for catabolism | Causal gene validation |
| Overexpression | Effect of increased enzyme levels | Flux enhancement |
| Neurophysiological assessment | Symptoms linked to phenylalanine derivatives | Aspartame studies |
Transcriptomics and metabolomics
Transcriptomic and metabolomic analyses have been used to dissect L-phenylalanine overproduction in Escherichia coli, revealing coordinated changes in catabolic and biosynthetic gene expression and metabolite pools. These methods are essential for mapping the flux through GO:0006559.
Enzymatic assays for L-phenylalanine catabolism
Enzyme assays using L-amino acid oxidases, such as the enzyme from Hebeloma cylindrosporum, measure the conversion of L-phenylalanine to phenylpyruvic acid and define kinetic properties of catabolic enzymes.
Metabolic engineering and flux analysis
Construction of recombinant Escherichia coli for production of L-phenylalanine-derived compounds allows researchers to test how catabolic pathway modifications affect product yield. Biotechnological 2-phenylethanol production studies similarly evaluate Ehrlich pathway flux.
Immunometabolic profiling
Studies in human Th2 cells have used metabolic profiling to show that L-phenylalanine acts as a metabolic checkpoint, providing a framework for investigating GO:0006559 in immune cells.
How CRISPR Can Be Used to Study GO:0006559 L-phenylalanine catabolic process
Knockout
CRISPR knockout models can delete candidate genes involved in L-phenylalanine catabolism to test whether they are required for the breakdown of L-phenylalanine or for downstream metabolite production. This approach is applicable to immune cell metabolic checkpoints and microbial pathway genes.
Point Mutation
Point-mutation models introduce specific amino acid substitutions to dissect catalytic residues or regulatory sites in enzymes such as L-amino acid oxidases and transaminases involved in L-phenylalanine catabolism.
Knock-in
Knock-in models can add tags or reporters to catabolic enzymes, enabling tracking of their localization and dynamics in cells. This is useful for studying pathway enzymes in both microbial and human cell contexts.
Overexpression
Overexpression models increase the levels of catabolic enzymes to enhance flux through L-phenylalanine breakdown and increase production of derived compounds such as 2-phenylethanol.
How EDITGENE Supports L-phenylalanine catabolic process Research
Researchers studying L-phenylalanine catabolic process-related genes often need to determine whether a candidate gene is causally involved in the breakdown of L-phenylalanine or in the production of its downstream metabolites. EDITGENE provides CRISPR-based cell models and screening services to enable such causal experiments.
Contact EDITGENE today to design your custom CRISPR model for L-phenylalanine catabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TAT Knockout HEK293 Cell Line | EDJ-KQ2159 | Human | 6898 | Details Get a Quote |
| IL4I1 Knockout HEK293 Cell Line | EDJ-KQ3808 | Human | 259307 | Details Get a Quote |
| PAH Knockout HEK293 Cell Line | EDJ-KQ3979 | Human | 5053 | Details Get a Quote |
| GSTZ1 Knockout HEK293 Cell Line | EDJ-KQ4816 | Human | 2954 | Details Get a Quote |
| HGD Knockout HEK293 Cell Line | EDJ-KQ4862 | Human | 3081 | Details Get a Quote |
| HPD Knockout HEK293 Cell Line | EDJ-KQ4931 | Human | 3242 | Details Get a Quote |
| GSTZ1 Knockout HeLa Cell Line | EDJ-KQ26373 | Human | 2954 | Details Get a Quote |
| HGD Knockout A-549 Cell Line | EDJ-KQ26430 | Human | 3081 | Details Get a Quote |
| HPD Knockout A-549 Cell Line | EDJ-KQ26559 | Human | 3242 | Details Get a Quote |
| GSTZ1 Knockout A-549 Cell Line | EDJ-KQ27592 | Human | 2954 | Details Get a Quote |
| GSTZ1 Knockout HCT 116 Cell Line | EDJ-KQ27593 | Human | 2954 | Details Get a Quote |
| HPD Knockout HeLa Cell Line | EDJ-KQ27771 | Human | 3242 | Details Get a Quote |
| FAH Knockout A-549 Cell Line | EDJ-KQ42832 | Human | 2184 | Details Get a Quote |
| FAH Knockout HCT 116 Cell Line | EDJ-KQ42833 | Human | 2184 | Details Get a Quote |
| FAH Knockout HeLa Cell Line | EDJ-KQ42834 | Human | 2184 | Details Get a Quote |
Displaying Records 1 To 15 Of 31 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About L-phenylalanine catabolic process
What is L-phenylalanine catabolic process?
It is the biological process defined by GO:0006559 that comprises the chemical reactions and pathways resulting in the breakdown of L-phenylalanine.
What genes are involved in L-phenylalanine catabolic process?
Genes encoding transaminases, L-amino acid oxidases, and Ehrlich pathway enzymes are involved, as shown in microbial and human cell studies.
What is the GO ID for L-phenylalanine catabolic process?
The GO ID is GO:0006559.
Why is L-phenylalanine catabolism important in immunology?
L-phenylalanine acts as a metabolic checkpoint in human Th2 cells, linking its catabolism to immune cell function.
How is L-phenylalanine converted to phenylpyruvate?
It can be converted by transamination or by oxidative deamination catalyzed by L-amino acid oxidases.
What is the Ehrlich pathway in L-phenylalanine catabolism?
The Ehrlich pathway converts L-phenylalanine-derived phenylpyruvate to 2-phenylethanol through decarboxylation and reduction.
Can L-phenylalanine catabolism be engineered in microbes?
Yes, recombinant Escherichia coli and yeast have been engineered to produce L-phenylalanine-derived compounds through these routes.
What diseases are linked to L-phenylalanine catabolism?
Altered L-phenylalanine handling has been associated with neurophysiological symptoms, and its checkpoint role is relevant to immune function.
What methods study L-phenylalanine catabolic process?
Transcriptomics, metabolomics, enzyme kinetics, and CRISPR-based models are commonly used.
How can CRISPR help study L-phenylalanine catabolism?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes in the pathway.
Conclusion
GO:0006559, L-phenylalanine catabolic process, is a fundamental biological process that governs the breakdown of an essential aromatic amino acid and the production of downstream metabolites. Its relevance spans immunometabolism, neurophysiology, and biotechnology, as demonstrated by studies in human Th2 cells, neurological symptom research, and engineered microbial production systems. CRISPR-based models provide powerful tools to dissect the causal roles of genes in this pathway, enabling both mechanistic discovery and translational applications.
References
- 1. Kulkarni AJ et al.. 2025. L-Phenylalanine is a metabolic checkpoint of human Th2 cells.. Cell Rep Med 6(12):102466 PMID: 41308641
- 2. Choudhary AK et al.. 2018. Neurophysiological symptoms and aspartame: What is the connection?. Nutr Neurosci 21(5):306-316 PMID: 28198207
- 3. Qiu M et al.. 2024. The biosynthesis of L-phenylalanine-derived compounds by engineered microbes.. Biotechnol Adv 77:108448 PMID: 39260779
- 4. Zeng L et al.. 2024. Poly(phenylalanine) and poly(3,4-dihydroxy-L-phenylalanine): Promising biomedical materials for building stimuli-responsive nanocarriers.. J Control Release 372:810-828 PMID: 38968969
- 5. Bernardino ARS et al.. 2024. Biotechnological 2-Phenylethanol Production: Recent Developments.. Molecules 29(23) PMID: 39683919
- 6. Liu L et al.. 2021. Construction of recombinant Escherichia coli for production of L-phenylalanine-derived compounds.. World J Microbiol Biotechnol 37(5):84 PMID: 33855641
- 7. Sun W et al.. 2023. Transcriptomics and metabolomics analysis of L-phenylalanine overproduction in Escherichia coli.. Microb Cell Fact 22(1):65 PMID: 37024921
- 8. Oike K et al.. 2020. Process properties of an l-amino acid oxidase from Hebeloma cylindrosporum for the synthesis of phenylpyruvic acid from l-phenylalanine.. J Biotechnol 323:203-207 PMID: 32653636
